Structural Bioinformatics-Based Design of Selective, Irreversible Kinase Inhibitors

See allHide authors and affiliations

Science  27 May 2005:
Vol. 308, Issue 5726, pp. 1318-1321
DOI: 10.1126/science1108367

You are currently viewing the abstract.

View Full Text


The active sites of 491 human protein kinase domains are highly conserved, which makes the design of selective inhibitors a formidable challenge. We used a structural bioinformatics approach to identify two selectivity filters, a threonine and a cysteine, at defined positions in the active site of p90 ribosomal protein S6 kinase (RSK). A fluoromethylketone inhibitor, designed to exploit both selectivity filters, potently and selectively inactivated RSK1 and RSK2 in mammalian cells. Kinases with only one selectivity filter were resistant to the inhibitor, yet they became sensitized after genetic introduction of the second selectivity filter. Thus, two amino acids that distinguish RSK from other protein kinases are sufficient to confer inhibitor sensitivity.

View Full Text